Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Akio Mori (Sagamihara, Kanagawa, Japan), Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, Akemi Ohtomo-Abe, Yosuke Kamide, Hiroaki Hayashi, Kentaro Watai, Chihiro Mitsui, Kiyoshi Sekiya, Takahiro Tsuburai, Yuma Fukutomi, Masami Taniguchi, Takayuki Ohtomo, Osamu Kaminuma. Synergistic suppression of T cell-induced eosinophilia by CTLA4-Ig and glucocorticoid in murine asthma model. Eur Respir J 2016; 48: Suppl. 60, 1098

Member's Comments

No comment yet.

Related content which might interest you: Effects of LTRA on T cell-induced bronchoconstriction in the mice Source: International Congress 2015 – New models for treating airway diseases Year: 2015 The effect of anti-IL-33 antibody and soluble ST2 in a murine model of allergic asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 LATE-BREAKING ABSTRACT: MUC1 downregulation induces corticosteroid resistance in asthma’s in vitro and in vivo models Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 CD38 gene-modified dendritic cells inhibit murine asthma development through increasing IL-12 production and promoting Th1 cell differentiation Source: International Congress 2016 – Immune responses in the lung Year: 2016 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Characterization of an endogenous Th17-cell generation during sensitization in the murine lung Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 LATE-BREAKING ABSTRACT: Triptolide modulates the CD4+ T cells balance in an allergic asthmatic mouse model Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Role of the T-cell homing receptor in the immune mechanisms of the allergic march Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 The role of IL-17 producing NK cells and other innate immune cells in poly(I:C) triggered exacerbation of experimental asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Weight gain alters adiponectin receptor 1 expression on lung-resident Foxp3+ Helios+ regulatory T cells: Implications during allergic airway inflammation? Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 IL-13 in a mouse model of chemical-induced airway hyperresponsiveness Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015